Proposed treatment guidelines for donor care
The complex care of the organ donor during preparation for organ removal and provision of the best organs for transplantation is often the responsibility of the organ procurement coordinator. To assist in that process the following clinical problem-based guidelines have been developed. A standard order set is recommended to initiate treatment and to provide a continuing laboratory database. As clinical concerns arise from that database, past medical history, or ongoing donor care, section of these guidelines may serve as references for specific interventions. Physician consultation and collaboration with other bedside care providers are encouraged throughout. (Progress in Transplantation. 2004; 14:16-28) Editor's Note: Individual treatment guidelines for advanced assessment of hemodynamic parameters for donor care can be accessed and downloaded at www.natco1.org or www.medscape.org. ment and treatment change to ensure that the best physiological support will be given to maximize the potential for successful organ transplantation. That transition is facilitated by policies that allow ongoing care orders be written by the coordinator and supported by the organ procurement organization's (OPO's) medical staff. Some previous treatment may no longer be appropriate for organ procurement, but many aspects of fundamental patient care should be continued. The coordinator should write orders to initiate standard donor care:
• Transfer care to (name of OPO).
• Discontinue all previous orders.
• Measure blood pressure, heart rate, temperature, urine output, central venous pressure (CVP; if central venous catheter is present), pulmonary artery occlusion pressure (PAOP; if pulmonary artery [PA] catheter is present) every hour.
• Reorder mechanical ventilator parameters as previously set.
• Maintain head of bed at 30° to 40° elevation.
• Continue routine pulmonary suctioning and side-to-side body positioning.
• Use warming blanket to maintain body temperature above 36.5°C.
• Maintain sequential compression devices.
• Continue chest tube suction or water seal (if present) as previously ordered.
• Set nasogastric (orogastric) tube (if present) to low intermittent suction.
• Administer intravenous (IV) fluid: 5% dextrose in 0.45% sodium chloride solution plus 20 mmol potassium chloride per liter at 75 mL/h.
• Call the OPO coordinator if the mean arterial pressure (MAP) is less than 70 mm Hg; systolic pressure, greater than 170 mm Hg; heart rate, fewer than 60 or more than 130 beats/min; temperature, less than 36.5°C or more than 37.8°C; urine output, less than 75 or more than 250 mL/h; CVP or PAOP, less than 8 or more than 18 mm Hg.
• Administer pantoprazole 40 mg intravenously every 24 hours, first dose stat; give artificial tears every hour and as needed to prevent corneal drying; administer albuteral and atrovent unit dose per aerosol every 4 hours; continue antibiotics previously ordered at same dose and frequency; and continue vasoactive drug infusions (eg, dopamine, norepinephrine) at previously ordered concentrations and infusion rates.
Review all medications previously ordered. Most medications (anticonvulsant agents, pain medications, laxatives, gas trointestinal [GI] motility agents, eye drops, antihypertensive and antinausea agents, subcutaneous heparin, osmotic agents [mannitol], and diuretic agents) are unnecessary during donor care and will be discontinued automatically as the care is transferred to the OPO. Review any other medications in question with the physician.
• Send blood samples to the laboratory at once for measurement of electrolytes, magnesium, ionized calcium, complete blood cell count, platelets, glucose, blood serum nitrogen, creatinine, phosphorous, arterial blood gas values, prothrombin time (PT), partial thromboplastin time (PTT), and resample every 4 hours.
• Send blood for type and screen with the preceding blood sample (if not previously done).
• Obtain finger-stick glucose values every 2 hours-contact the OPC if the glucose level is less than 5.0 mmol/L (90 mg/dL) or greater than 10.0 mmol/L (180 mg/dL).
• Obtain an electrocardiogram (ECG) at once.
• Obtain a chest radiograph at once-indication: initial donor evaluation.
• Add other orders for specific organ evaluation as indicated.
This order set provides a "safety net" of call orders so that the coordinator is alerted to significant changes in the donor's status. It also prescribes the foundation for ongoing monitoring of physiological and laboratory variables.
Donor care is subsequently directed and "finetuned" through the treatment guidelines that follow. These guidelines include treatment plans for hypertension, hypotension, glucose management, temperature, anemia, coagulopathy and thrombocytopenia, mechanical ventilation, fluid and electrolyte treatment, polyuria, and acid-base changes. Each may be referenced as that circumstance or problem arises. Although the guidelines are not intended to compartmentalize the complex process of overall donor care, they may provide useful resources in methods of treatment, precautions, and points at which physician consultation is appropriate.
Guideline for Donors With Hypertension
It is unusual for hypertension to occur after brain death, although it is common during the evolution of brain death. Because donor organs are likely at more risk from hypotension than hypertension, a conservative treatment plan is recommended. The goal for MAP is less than 90 mm Hg when the donor is hypertensive, but always above 65 to 70 mm Hg. The MAP is measured via an intra-arterial catheter, a noninvasive blood pressure device, or calculated using the following formula: diastolic pressure + 1/3(systolic -diastolic pressures) + 5. Therapy should be started if the MAP is sustained above 95 mm Hg for 30 minutes after certification of brain death. Placement of the arterial catheter in an upper extremity is preferred.
Treatment
• Reduce or discontinue inotropic or vasopressor medications or infusions.
• If the difference between the MAP recorded via an arterial catheter and noninvasive device is greater than 20 mm Hg, discuss which blood pressure to follow with the consultant physician. Differences in measurements taken from an automatic oscillometric noninva-sive device and an arterial catheter may be due to several technical factors. 8, 9 • Give a labetalol 10-mg IV bolus every 20 minutes until the MAP goal of 65 to 70 mm Hg is reached. If the MAP goal is not achieved after 2 doses, administer a nicardipine IV infusion-start infusion at 5 mg/h and titrate up to 10 mg/h to achieve the MAP goal.
• If the MAP goal is not achieved after titration of nicardipine to 10 mg/h, consult physician.
Guidelines for Donors With Hypotension
Hypotension commonly follows brain death and may be caused by ongoing or preexisting conditions leading to hemorrhagic, cardiogenic, distributive, or obstructive types of "shock." In the absence of these preexisting conditions causing shock, hypotension commonly occurs after brain death due to loss of vasomotor centers in the brain causing vasodilation, decreased contractility of the heart, or hypovolemia due to ongoing fluid loss due to diabetes insipidus. Hypotension will be defined as MAP less than 60 mm Hg as measured from an indwelling arterial catheter, noninvasive blood pressure machine, or calculated using the following formula: diastolic pressure + 1/3 [systolicdiastolic pressure] + 5. Placement of an arterial catheter for monitoring is desirable, and insertion in an upper extremity is preferred. The treatment goal for MAP is 65 to 75 mm Hg.
Assessment
• Review the medical record for evidence of recent blood loss. Confirm that the most recent hematocrit value is greater than 0.28 (28%) and reaffirm with an immediate repeat hematocrit value. Refer to the Anemia and Coagulopathy treatment guidelines and treat as indicated if the hematocrit value is less than 0.28 (28%) or a coagulation disorder is present.
• Review the medical record for evidence of concomitant myocardial ischemia or infarction during this admission. Repeat ECG and maintain at bedside. Consult physician for ECG interpretation.
• Review the medical record for evidence of excessive fluid losses above intake (output > intake by >1500 mL in last 24 hours) during current hospitalization. If polyuria is present, refer to the Polyuria treatment guideline.
• Review current patient status for a central venous catheter and evaluate CVP or PAOP. The goal is to maintain both at 12 to 15 mm Hg. If a PA catheter is present, obtain information regarding cardiac output, cardiac index, systemic vascular resistance index (SVRI), and left ventricular stroke work index.
• Review the medical record for evidence of ongoing severe infection, drug or other allergic reactions (eg, due to transfusion), pericardial effusion, or pneumothorax. Obtain a chest radiograph and consult physician for its interpretation.
Treatment
• Ensure that any signs of continuing hemorrhage (eg, external, GI, urinary, abdominal) have been evaluated and that interventions have been initiated.
• Discontinue medications that may contribute to hypotension (eg, antihypertensives, β-blockers).
• The general principle of treatment is to first ensure that adequate intravascular volume (preload) is present, as evidenced by a CVP and/or PAOP greater than 12 mm Hg.
• Begin treatment with a crystalloid solution such as 0.9% isotonic sodium chloride solution or Ringer's lactate. Colloid solutions may be added and may be preferable for repeated fluid challenges (5% albumin, 250 or 500 mL). Thereafter, either inotropic or vasopressor medications will be infused and titrated to the MAP goal or other hemodynamic parameters. If a PA catheter is available or at any time is inserted, a cardiac/hemodynamic profile should be obtained. If the donor demonstrates a low SVRI (<1400 dyne·s·m 2 /cm 5 ) a vasopressor (eg, norepinephrine, phenylephrine) is the vasoactive drug of choice and subsequently titrated to maintain the MAP greater than 60 mm Hg. If the left ventricular stroke work index is low (<35 g·m/m 2 ), a positive inotropic agent (eg, dopamine, dobutamine) should be used. The algorithm in Figure 2 assumes that if the MAP, CVP, heart rate, and PAOP goals are reached, vital signs will continue to be monitored. Vasoactive medications should be weaned and removed as soon as possible, while maintaining the MAP goal. Subsequent deviations from goal values may require return to the guidelines.
Guideline for Glucose Management in Donors
Both hypoglycemia and hyperglycemia may harm donor organs. Measure serum glucose every 4 hours and obtain finger-stick glucose per glucometer every 2 hours unless as described below.
Hypoglycemia
• Treat less than 4.2 mmol/L (75 mg/dL).
• Give 1 premixed syringe of 50% dextrose.
• Repeat glucose or obtain finger-stick glucose in 30 minutes and repeat 50% dextrose if the glucose level is less than 4.2 mmol/L (75 mg/dL).
• If the laboratory or finger-stick glucose remains less than 4.2 mmol/L (75 mg/dL) after 2 doses of 50% dextrose, consult physician.
Hyperglycemia
• Ensure that glucose is removed from all IV fluids and infusions unless required by pharmacy.
•
Figures 3 and 4 show a subcutaneous insulin
Proposed treatment guidelines for donor care sliding scale and a supplemental IV insulin regimen. Give subcutaneous insulin no more often than every 4 hours. When supplemental IV insulin is also needed, give the IV insulin bolus prescribed by the IV sliding scale every hour after the hourly finger-stick glucose. Stop IV insulin when the blood sugar level drops below 13.9 mmol/L (250 mg/dL).
• In summary, hyperglycemia is treated by first removing sources of exogenous glucose, followed by subcutaneous insulin every 4 hours ( Figure 3 ). Supplemental IV insulin is given each hour thereafter, as shown in Figure 4 , only if the blood glucose remains above 12.5 mmol/L (225 mg/dL).
• If the glucose level remains greater than 13.9 mmol/L (250 mg/dL) 4 hours after the initial subcutaneous insulin and subsequent IV insulin therapy, consult physician to discuss an insulin infusion.
Guideline for Temperature Management in Donors
Brain death usually causes loss of thermal regulation in the donor, commonly resulting in hypothermia. The temperature goal is 36°C to 37.5°C (97°F to 99.5°F).
Hypothermia
• The preferred method of body temperature measurement is from a core site, such as a PA catheter or bladder (specialized catheter). Axillary temperatures should not be used, and oral temperatures are less accurate in hypothermia. Rectal temperatures can be used if hypothermia is not severe (>35°C).
• Use active surface warming with a heated liquid or hot air warming blanket plus insulating thermal blankets.
• Warm the inspired gas from the ventilator to 38.5°C (101.3°F).
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Abbreviations: CVP, central venous pressure; MAP, mean arterial pressure; PA, pulmonary artery; PAOP, pulmonary artery occlusion pressure. • If temperature remains less than 36°C (97°F) after 3 hours of attempted rewarming, consult physician.
Hyperthermia (Unusual After Brain Death)
• Remove unnecessary blankets.
• Do not cool inspired gas.
• Administer acetaminophen 650 mg per suppository or per gastric tube every 3 hours.
• Use automated fluid filled cooling blanket.
• If temperature remains greater than 38.4°( 101°F) after 3 hours of cooling, consult physician.
Guideline for Anemia in Donors
Although the differential diagnosis for anemia may be extensive, during donor care the most likely causes are continuing blood loss or excessive blood draws for laboratory testing. Hemolysis may rarely occur. The goal is to maintain the hematocrit level above 0.30 (30%).
Assessment
• Review the medical record for evidence of bleeding sites, previous blood transfusions and their frequencies, or other information about blood loss or hemolysis.
• Observe for signs of ongoing bleeding from external wounds and IV sites; GI tract, via gastric tube or bowel movements (observe for abdominal distension and/or firmness and changes during repeat abdominal assessment); and urinary tract, by observation or laboratory assessment for blood in urine.
• Refer to the Coagulopathy treatment guideline. Obtain PT, PTT, fibrinogen, and platelet count and treat as indicated.
• If the hematocrit level is 0.28 (28%) to 0.30 (30%) and no signs of bleeding are present, begin hematocrit measurements every 4 hours.
• If the hematocrit level is 0.28 (28%) to 0.30 (30%) and no gastric tube is in place, insert orogastric tube and lavage stomach to assess for upper GI blood.
Treatment
• If prior transfusions have been required, submit blood bank order to maintain 2 to 4 units of packed red blood cells (PRBCs) available. Otherwise, write order to type and cross-match and maintain 2 units PRBCs available.
• If the hematocrit level is less than 0.30 (30%), transfuse 2 units PRBC rapidly.
• Reassess the hematocrit level 1 hour after the last unit of PRBC was infused and repeat transfusion if the hematocrit level is less than 0.30 (30%).
• Reassess the hematocrit level 1 hour after giving the fourth unit of PRBC and reconsider above assessment items. If the hematocrit level is less than 0.30 (30%) after administering 4 units of PRBC, consult physician.
Guideline for Treating Coagulopathy and Thrombocytopenia in Donors
Blood loss from any cause may endanger continued perfusion to donor organs. Disseminated intravascular coagulation or a "dilutional" coagulopathy may occur after severe trauma and resuscitation. The treatment goal is to correct clinically important coagulopathy and thrombocytopenia. Because ongoing hemorrhage may worsen coagulation abnormalities and/or thrombocytopenia, refer to the Anemia treatment guideline, and correct disorders noted.
It is recognized that commonly performed laboratory tests of coagulation, that is, PTT, PT, fibrinogen, and platelet count may be abnormal but treatment may not be required. Treatment is reserved for donors who appear to have continuing significant blood loss evidenced by physical assessment, hemodynamic instability, and changes in coagulation parameters. 
Assessment
• The donor's medical record should be reviewed for any possible injury that may account for bleeding. If such injury is found, discuss with physician.
• Review the medical record to ensure that no drugs that might interfere with coagulation or platelet function have recently been given; for example, warfarin (Coumadin), aspirin, heparin, clopidogrel (Plavix), and dypyridamole. Notify physician if recent administration is documented.
• Send PT, PTT, fibrinogen, platelet count to the laboratory and repeat coagulation tests 30 minutes after any administration of blood products. Normal values are PT less than 14.5 seconds, platelet count more than 150 × 10 9 (150 000/mL 3 ), PTT less than 35.6 seconds, and fibrinogen 4.4 to 10.3 µmol/L (150-350 mg/dL).
• Measure ionized calcium (refer to the Fluid and Electrolyte treatment guideline) and treat hypoionized calcemia at less than 1.15 mmol/L (2.30 mEq/L).
Treatment of Continued Signs of Significant Blood Loss and Associated Abnormal Coagulation Results or Platelet Count
• Consult physician for external bleeding or further assessment of possible GI or urinary injury. Treat anemia per the Anemia treatment guideline.
Platelets. Platelet dysfunction due to previous aspirin intake can be overcome by infusing a platelet 5-pack dose even though the platelet count is normal. Discuss with physician. Otherwise, treat for platelet count less than 65 × 10 9 (65 000/mL 3 ).
• Transfuse 1 platelet pack (usually 5 or 6 individual units of platelets) intravenously as a rapid infusion.
• Recheck platelet count 1 hour after first platelet pack and transfuse second platelet pack if the platelet count remains less than 65 × 10 9 (65 000/mL 3 ). Obtain follow-up platelet count exactly 1 hour after second platelet infusion is completed.
• If platelet count remains less than 65 × 10 9 (65 000/mL 3 ) after second platelet infusion, consult physician.
Coagulopathy (increased PT and PTT)-Treat PT greater than 15 seconds and PTT greater than 38 seconds
• If the donor had been receiving IV heparin and PTT is greater than 75 seconds, discuss administration of protamine with physician.
• Rapidly infuse 4 units fresh frozen plasma (FFP).
• Repeat PT and PTT measurements 30 minutes after initial FFP infusion-repeat FFP infusion if PT and PTT remain above treatment ranges.
• Repeat PT and PTT measurements 30 minutes after second FFP infusion-if PTT and PT remain elevated above treatment ranges, consult physician.
Coagulopathy (decreased fibrinogen)-Treat fibrinogen less than 2.9 µmol/L (100 mg/dL)
• Infuse 6 units cryoprecipitate, rapidly.
• Repeat fibrinogen 1 hour after initial cryoprecipitate infusion-repeat infusion of cryoprecipitate if fibrinogen remains less than 2.9 µmol/L (100 mg/dL).
• Repeat fibrinogen 1 hour after second infusion of cryoprecipitate. If concentration remains less than 2.9 µmol/L (100 mg/dL), consult physician.
Guideline for Donors Receiving Mechanical Ventilation
Under most circumstances, volume-limited controlled mechanical ventilation will be used during donor care. Pressure-limited controlled mechanical ventilation is indicated when peak and plateau airway pressures are elevated, indicating high airway resistance or poor lung compliance. Table 1 shows the goals during mechanical ventilation.
Assessment
• Evaluate the medical record for cardiopulmonary diseases before or during this admission. Assess related issues such as chronic oxygen use at home, ongoing pneumonia, chest radiograph results, culture results, antibiotics ordered, and respiratory treatments given.
• Ensure that recent arterial blood gas (ABG) results are available or obtain sample for testing. Compare results to treatment goals (Table 1) .
• Perform a physical examination with attention to abnormalities such as wheezing; rhonchi; and sputum appearance, thickness, and tenacity.
• Obtain repeat ABG values at least every 4 hours, or more frequently, to assess changes in respiratory status or after adjustments in ventilator settings.
• Consult with a respiratory care practitioner to identify if the mechanical ventilation goals (Table 1) are being met.
General Ventilator Settings
Volume-Limited Controlled Ventilation • Tidal volume (VT)-10 mL/kg ideal body weight (kg). If high peak airway pressures are present, reduce VT to 6 to 8 mL/kg ideal body weight (kg).
- • Adjust the fraction of inspired oxygen (FIO 2 ) to maintain PaO 2 above 70 mm Hg.
• Use decelerating (ramp) pattern for flow delivery, when available.
Pressure-Limited Controlled Ventilation
• Adjust inspiratory pressure setting to limit peak airway pressure at 35 to 40 cm H 2 O; consult with respiratory care practitioner for final pressure limit setting because of various ventilator types.
• Rate, same as for volume-limited controlled ventilation.
• PEEP, same as for volume-limited controlled ventilation. However, PEEP adjustments may change delivered VT and VE during pressure-limited ventilation, that is, increased PEEP will generally decrease VT and VE causing PaCO 2 to rise (reverse with decreased PEEP).
• FIO 2 , same as for volume-limited controlled ventilation.
General Respiratory Treatments
• Ensure adequate suctioning of excessive sputum.
• Ensure that bronchodilators are ordered as indicated by wheezing or a peak airway pressure-plateau airway pressure gradient of greater than 10 cm H 2 O.
• Other forms of chest physiotherapy or related devices are optional but should be considered.
Ventilator Adjustments
Volume-Limited Controlled Ventilation.
• Repeat ABG testing 30 minutes after any change of ventilator settings to assess effects. Combinations of adjustments listed below may be necessary as guided by ABG results and airway pressures.
Acidemic pH-arterial pH <7.35
• Increase VT to maximum 12 mL/kg ideal weight as long as plateau airway pressure remains less than 35 cm H 2 O, or increase rate to maximum 22 breaths/min as long as auto-PEEP remains less than 5 cm H 2 O.
• If pH remains less than 7.32 after these changes, refer to the Acid-Base treatment guideline.
Alkalemic pH (arterial pH >7.45)
• Decrease ventilator rate sequentially to minimum of 6 breaths/min to achieve pH goal.
• Decrease VT to minimum of 6 mL/kg ideal body weight.
• If pH remains greater than 7.45, consult physician.
High plateau airway pressure (>35 cm H 2 O)
• Reduce flow rate to minimum 50 L/min-as long as auto-PEEP remains less than 5 cm H 2 O.
• Reduce VT to minimum of 6 mL/kg ideal body weight-assess effect on arterial pH.
• Reduce PEEP to minimum 5 cm H 2 O-assess effect on PaO 2 .
• If plateau airway pressure remains greater than 35 cm H 2 O, consult physician.
Auto-PEEP greater than 5 cm H 2 O
• Increase flow rate to maximum of 90 L/min-as long as plateau airway pressure remains less than 35 cm H 2 O.
• Decrease VT to minimum 6 mL/kg ideal body weight-assess effect on arterial pH.
• Decrease ventilator rate sequentially to minimum of 8 breaths/min to minimize auto-PEEPassess effect on arterial pH.
• If auto-PEEP remains greater than 5 cm H 2 O, consult physician.
Low PaO 2 <70 mm Hg
• Increase FIO 2 to maximum 1.0 (100%).
• Increase PEEP to maximum 15 cm H 2 O-as long as plateau airway pressure remains less than 35 cm H 2 O.
• Add inspiratory pause (hold) to maximum 1.0 seconds as long as auto-PEEP remains less than 5 cm H 2 O.
• If PaO 2 remains less than 70 mm Hg, consult physician.
Pressure-Limited Controlled Mechanical Ventilation Acidemic pH (arterial pH <7.35)
• Increase ventilator rate to maximum 22 breaths/ min, as long as auto-PEEP less than 5 cm H 2 O. (Auto-PEEP will decrease VT delivered and may worsen acidemia.)
• Increase inspiratory pressure setting to maximum peak airway pressure of 45 cm H 2 O. • If arterial pH remains less than 7.32, consult physician.
Alkalemic pH (arterial pH >7.45)
• Decrease ventilator rate sequentially to minimum of 6 breaths/min to achieve pH goals.
• Decrease inspiratory pressure setting but maintain VT above 6 mL/kg ideal body weight.
• If arterial pH remains greater than 7.45, consult physician.
Auto-PEEP (>5 cm H 2 O)
• Decrease ventilator rate sequentially to minimum 8 breaths/min-assess effect on arterial pH.
• If greater than 5 cm H 2 O auto-PEEP persists, consult physician.
Low PaO 2 (< 70 mm Hg)
• Increase ventilator PEEP to maximum of 15 cm H 2 O as long as pH remains greater than 7.35 (increased PEEP will decrease VT delivered in pressure-limited ventilation).
Guideline for Management of Fluids and Electrolytes in Donors
The treatment goal is to maintain electrolytes within the normal limits established by the clinical laboratory in each hospital. To achieve that goal, laboratory testing of sodium, potassium, chloride, bicarbonate, magnesium, phosphorous, and ionized calcium should be completed every 4 hours. More frequent testing may be needed to monitor and treat critical levels. Any testing should be delayed for 30 minutes after the last dose of the electrolyte being treated. All electrolyte replacement should be by the IV route. Table 2 shows normal values for these variables.
Sodium

Hypernatremia-treat sodium level greater 150 mmol/L
• With polyuria (>250 mL of urine above intake per hour)-see Polyuria treatment guideline.
• Without polyuria-give 1 liter 0.2% sodium chloride solution as rapid infusion and replace urine output mL/mL per hour with 0.2% sodium chloride solution. Ensure that all medications are mixed in 0.45% (1/2 isotonic) sodium chloride solution or 0.2% sodium chloride solution if pharmaceutically possible and that any maintenance IV fluid is 5% dextrose in 0.2% sodium chloride solution. Avoid use of diuretics.
Hyponatremia-treat for serum sodium less than 133 mmol/L (133 mEq/L)
• Mix all medications in isotonic (0.9%) sodium chloride solution if pharmaceutically possible. Change maintenance IV to 5% dextrose in 0.9% sodium chloride solution.
• If hyperglycemia is present, the serum sodium level may be low because of the high blood glucose. If the blood sugar level is greater than 16.6 mmol/L (300 mg/dL), a "corrected" serum sodium level may be calculated by adding to the measured sodium-1.6 mmol/L (1.6 mEq/L) for each 100 g/dL of blood glucose above 100 mg/dL; see the Hyperglycemia treatment guideline.
• If the sodium level is less than 128 mmol/L (128 mEq/L), give 3% sodium chloride solution per infusion (central catheter preferred) at 40 mL/h for 3 hours.
• If the sodium level remains less than 133 mmol/L (133 mEq/L) after the 3% sodium chloride infusion, consult physician. • Do not treat potassium if the laboratory reports that the specimen is "hemolyzed"-send a new specimen for testing.
• Ensure that all potassium is removed from current infusions.
• Measure serum levels of potassium every hour.
• Give 50 mL of 5% dextrose (1 prefilled syringe), 15 units regular humulin insulin, and 1 ampoule sodium bicarbonate (44 or 50 mmol via prefilled syringe) intravenously.
• If the potassium level is greater than 5.8 mmol/L (5.8 mEq/L) after intervention, consult physician.
Hypokalemia-treat if less than or equal to 3.4 mmol/L
• Delay administration of any diuretic.
• Give 20 mmol (20 mEq) potassium chloride over 1 hour (central catheter preferred) as 2 doses if serum potassium is less than 3.4 mmol/L (3.4 mEq/L), 3 doses if serum potassium is less than 3.1 mmol/L (3.1 mEq/L), and 4 doses if serum potassium is less than 2.9 mmol/L (2.9 mEq/L).
• If the potassium level remains greater than 2.9 mmol/L (2.9 mEq/L) or less than 3.8 mmol/L (3.8 mEq/L), repeat the intervention. 
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Chloride
Chloride is not independently treated.
Bicarbonate
Bicarbonate is not independently treated.
Magnesium
Hypermagnesemia is not independently treated. Hypomagnesemia-treat magnesium less than 0.62 mmol/L (1.5 mg/dL) • Administer 4 g magnesium sulfate over 2 hoursrepeat as indicated by subsequent laboratory assessments to maintain above goal levels.
• If the magnesium level remains less than 0.62 mmol/L (1.5 mg/dL) after administration of 8 g magnesium sulfate, consult physician.
Phosphorus
Hyperphosphatemia is not independently treated. Hypophosphatemia-treat serum phosphorous less than 0.71 mmol/L (2.2 mg/dL) • Give 30 mmol potassium or sodium phosphate over 3 hours and repeat (total 2 doses).
• If the phosphate level remains less than 0.71 mmol/L (2.2 mg/dL) after 60 mmol sodium or potassium phosphate had been given, consult physician.
Calcium
Measure and treat only the ionized calcium value. Hyperionized calcemia is not separately treated. Withhold additional calcium.
Hypoionized calcemia-treat less than 1.1 mmol/L (4.4 mg/dL).
• Give 10 mL 10% solution of calcium gluconate slow IV push.
• Remeasure ionized calcium in 1 hour.
• Repeat if ionized calcium is low. • If the ionized calcium level remains low after 20 mL 10% calcium gluconate is given, consult physician.
Guideline for Treating Polyuria in Donors
Polyuria may quickly lead to hypovolemia and hypoperfusion of donor organs. The causes of polyuria may be (1) physiological diuresis after previous fluid administration, (2) osmotic diuresis because of previous mannitol therapy or continuing hypergly cemia, (3) diuresis from prescribed diuretics, or (4) diabetes insipidus. Physiological diuresis does not lead to hypotension, but all other forms may. If the donor demonstrates hypotension and polyuria, continue in this guideline, but refer also to the Hypotension treatment guideline. The urine output goal is 75 to 150 mL/h.
Initial Assessment
• Evaluate blood sugar per laboratory or finger-stick measurement. Glucose values greater than 11.1 mmol/L (200 mg/dL) may contribute to polyuria. Refer to the Glucose Management treatment guideline.
• Stop any prescribed diuretic therapy.
• Calculate recent fluid intake/output balance and adjust intake to be 100 mL/h less than total output. For example, you observe that urine output over the last 3 hours averaged about 400 mL/h. Adjust total IV fluid intake to equal about 300 mL/h.
• Measure serum sodium and glucose levels every 2 hours.
• If the sodium level is greater than 148 mmol/L (148 mEq/L)-assume excessive free water loss has occurred, and proceed with treatment plan below.
• If the serum sodium level was 135 to 147 mmol/L (135-147 mEq/L) when last measured, observe urine output and repeat serum sodium measurements. Maintain fluid intake 100 mL less than urine output each hour.
Treatment
• Stop excessive intake (maintain intake 100 mL less than output until intake and output are equal and then maintain intake = output).
• If the urine output is greater than 250 mL more than IV intake for the last 2 hours and the serum sodium level was greater than 145 mmol/L when last measured, give 1µg IV desmopressin.
• Begin replacement of urine output each hour mL/mL with 0.2% saline (1/2 isotonic sodium chloride solution, no dextrose).
• If urine output has not declined below 200 mL above intake (urine output >200 mL above fluid intake) in the next hour, give an additional 1 µg of desmopressin intravenously.
• If urine output has not decreased to less than 200 mL above IV intake (urine output >200 mL above fluid intake) and sodium has not fallen to less than 146 mmol/L in 2 additional hours, consult physician.
Guideline for Acid-Base Management in Donors
During donor care monitoring and treating, the arterial pH becomes the primary acid-base goal. Because there are few primary effects of hypocarbia or hypercarbia, the PaCO 2 will be adjusted to normalize the arterial pH (7.35-7.45 ). Modifications of the mechanical ventilator to alter the PaCO 2 , and hence pH, are reviewed in the Mechanical Ventilation treatment guideline.
Powner et al
Assessment
Because hospitals may report either the Base Excess (BE) or Base Deficit (BD) with ABG results, both are included here.
Acidosis. Review the ABG measurement obtained before manipulation of the mechanical ventilator recommended in the Mechanical Ventilation treatment guideline. Assess the BE or BD provided as part of the ABG results. If the BE is more negative than -6 or the BD is more positive than +6, metabolic acidosis is likely present.
Alkalosis. Review the ABG measurement before adjustment of the mechanical ventilator as above. If the BE is more positive than +6 or BD is more negative than -6, metabolic alkalosis is likely present, although very unusual during donor care.
Treatment
Metabolic Acidosis. If the arterial pH remains less than 7.32 after the changes recommended in the Mechanical Ventilation treatment guideline, administer 1 premixed syringe (44 or 50 mmol) sodium bicarbonate by slow IV bolus. However, if the sodium is concurrently greater than 150 mmol/L (150 mEq/L), consult physician before giving sodium bicarbonate. If the arterial pH remains less than 7.32 after retesting in 30 minutes, repeat the sodium bicarbonate administration. If the arterial pH remains less than 7.32 thereafter, consult physician.
Metabolic Alkalosis. If the arterial pH remains greater than 7.45 after the changes recommended in the Mechanical Ventilation treatment guideline, consult physician.
